The testing material was applied to both scarified and non-scarified skin on the flank (0.5 ml on a 6 cm2 area, with hair clipped) under an occlusive hypoallergenic dressing for 24 hours
(ACTIVATOR): Aqua (Water), Glycerin, Tripeptide-29, Tripeptide-1, Myristoyl Nonapeptide-3, Trifluoroacetyl Tripeptide-2, Acetyl Tetrapeptide-2, Sodium Hyaluronate Crosspolymer, Glycogen, Propanediol, Pentylene Glycol, Dextran, Dimethyl Isosorbide, Ethoxydiglycol, Isoceteth-20, Leuconostoc/Radish Root Ferment Filtrate, Caprylyl Glycol, Ethylhexylglycerin, Phenoxyethanol, Chlorphenesin
For skin concerns, GHK-Cu alone addresses collagen support
Related dosage pages: For vial-specific concentration, reconstitution, and measurement examples, see GHK-Cu (50 mg Vial) Dosage Protocol and GHK-Cu (100 mg Vial) Dosage Protocol
Safety and outcomes of a plasmid DNA vaccine encoding the ERBB2 intracellular domain in patients with advanced-stage ERBB2-positive breast cancer: a phase 1 nonrandomized clinical trial
Furthermore, a comprehensive review published in the Journal of Translational Medicine proposed a unifying model for ME/CFS and Long COVID, highlighting how viral infections (like SARS-CoV-2 or Epstein-Barr Virus) trigger a cascade of immune exhaustion, micro-clotting, and severe oxidative stress